Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

CIR Nearly Finished Assessing Citrus Component Safety

This article is powered by The Rose Sheet

Executive Summary

Three years after initiating safety reviews of citrus substances, the Cosmetic Ingredient Review Expert Panel is on the verge of wrapping its work in the area. At its Sept. 19-20 meeting in Washington, the expert panel issued final safety assessments for six ingredient groups in total.

Advertisement

Related Content

CIR Panel Plans For Lead Acetate Review At FDA’s Request
Cosmetic Ingredient Review Report Status
CIR Panel Emphasizes GMPs In Final 'Safe As Used' Ingredient Reports
California’s Prop 65 List Grows With Addition Of Beta-Myrcene
Viability Of Preservative MI Use Remains Unclear; CIR Tables Review
ICCR Ushers Forth Updated Cosmetic GMP Guidelines From FDA
CIR Sets 2013 Review Priorities Based On Frequency Of Use

Topics

Advertisement
UsernamePublicRestriction

Register

RS108609

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel